BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 214 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,355 | -3.6% | 126,545 | +21.3% | 0.00% | 0.0% |
Q2 2023 | $6,594 | +44.5% | 104,347 | +2.9% | 0.00% | +100.0% |
Q1 2023 | $4,562 | -16.2% | 101,400 | -18.3% | 0.00% | 0.0% |
Q4 2022 | $5,441 | -99.9% | 124,186 | +68.1% | 0.00% | -60.0% |
Q3 2022 | $4,867,000 | +279.0% | 73,869 | +190.4% | 0.01% | +400.0% |
Q2 2022 | $1,284,000 | -27.8% | 25,441 | -8.7% | 0.00% | 0.0% |
Q1 2022 | $1,779,000 | -88.6% | 27,868 | -80.8% | 0.00% | -66.7% |
Q4 2021 | $15,544,000 | +243.1% | 145,120 | +229.2% | 0.00% | +50.0% |
Q3 2021 | $4,531,000 | +377.4% | 44,079 | +307.9% | 0.00% | – |
Q2 2021 | $949,000 | -82.5% | 10,807 | -80.6% | 0.00% | -100.0% |
Q1 2021 | $5,412,000 | +47.3% | 55,668 | +69.9% | 0.00% | +50.0% |
Q4 2020 | $3,675,000 | -1.7% | 32,767 | -18.7% | 0.00% | 0.0% |
Q3 2020 | $3,739,000 | -60.8% | 40,307 | -67.0% | 0.00% | -71.4% |
Q2 2020 | $9,535,000 | +184.3% | 122,250 | +113.2% | 0.01% | +133.3% |
Q1 2020 | $3,354,000 | -61.4% | 57,338 | -47.2% | 0.00% | -40.0% |
Q4 2019 | $8,694,000 | +321.6% | 108,528 | +286.8% | 0.01% | +400.0% |
Q3 2019 | $2,062,000 | -70.5% | 28,060 | -62.2% | 0.00% | -75.0% |
Q2 2019 | $6,998,000 | +201.6% | 74,187 | +156.0% | 0.00% | +100.0% |
Q1 2019 | $2,320,000 | +1181.8% | 28,979 | +766.9% | 0.00% | – |
Q4 2018 | $181,000 | -97.4% | 3,343 | -96.3% | 0.00% | -100.0% |
Q3 2018 | $7,089,000 | +457.7% | 90,814 | +354.0% | 0.01% | +500.0% |
Q2 2018 | $1,271,000 | +15.0% | 20,003 | +65.9% | 0.00% | 0.0% |
Q1 2018 | $1,105,000 | +58.3% | 12,057 | +30.4% | 0.00% | 0.0% |
Q4 2017 | $698,000 | +243.8% | 9,247 | +217.1% | 0.00% | – |
Q3 2017 | $203,000 | +58.6% | 2,916 | +15.2% | 0.00% | – |
Q2 2017 | $128,000 | -79.3% | 2,532 | -83.6% | 0.00% | -100.0% |
Q1 2017 | $618,000 | +653.7% | 15,455 | +431.5% | 0.00% | – |
Q4 2016 | $82,000 | +1071.4% | 2,908 | +1096.7% | 0.00% | – |
Q3 2016 | $7,000 | 0.0% | 243 | -26.4% | 0.00% | – |
Q2 2016 | $7,000 | +250.0% | 330 | +153.8% | 0.00% | – |
Q1 2016 | $2,000 | -83.3% | 130 | -73.0% | 0.00% | – |
Q4 2015 | $12,000 | -14.3% | 482 | -28.4% | 0.00% | – |
Q3 2015 | $14,000 | -33.3% | 673 | -16.3% | 0.00% | – |
Q2 2015 | $21,000 | – | 804 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |